Form 4: Angi Inc. Executive Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Kulesh Shanmugasundaram, Chief Technology Officer of Angi Inc., sold 11,748 shares of Class A Common Stock at an average price of $2.58 on March 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 6, 2024, Kulesh Shanmugasundaram, the Chief Technology Officer of Angi Inc., sold 11,748 shares of Class A Common Stock.
- The sale was executed at a weighted average price of $2.58 per share, with prices ranging from $2.53 to $2.69.
- The transaction was conducted under a Rule 10b5-1 trading plan previously adopted by Shanmugasundaram.
- Following the reported transaction, Shanmugasundaram directly owns 160,060 shares of Angi Inc. Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of an insider stock sale under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, indicating a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives. The use of a 10b5-1 trading plan suggests the insider planned these transactions in advance to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of the transaction: Sale of 11,748 shares of ANGI Class A Common Stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.